quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:04:14·807d
SECFiling
Chenghe Acquisition Co. logo

Chenghe Acquisition Co. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

CHEA· Chenghe Acquisition Co.
Finance
Original source

Companies

  • CHEA
    Chenghe Acquisition Co.
    Finance

Related

  • INSIDER787d
    Chenghe Investment Co. converted options into 2,697,561 units of Class A Ordinary Shares and returned 2,697,561 units of Class A Ordinary Shares to the company (SEC Form 4)
  • INSIDER787d
    Ma Ning converted options into 20,000 units of Class A Ordinary Shares and returned 20,000 units of Class A Ordinary Shares to the company (SEC Form 4)
  • SEC787d
    SEC Form 15-12G filed by Chenghe Acquisition Co.
  • INSIDER787d
    Ewing Robert D returned 20,000 units of Class A Ordinary Shares to the company and converted options into 20,000 units of Class A Ordinary Shares (SEC Form 4)
  • INSIDER787d
    Sun Kwan converted options into 20,000 units of Class A Ordinary Shares and returned 20,000 units of Class A Ordinary Shares to the company (SEC Form 4)
  • 13D/G791d
    SEC Form SC 13G/A filed by Chenghe Acquisition Co. (Amendment)
  • SEC798d
    SEC Form 25-NSE filed by Chenghe Acquisition Co.
  • SEC798d
    Chenghe Acquisition Co. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Control of Registrant, Material Modification to Rights of Security Holders, Leadership Update, Other Events, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022